Performance and pilot clinical validation of MALDITEC-CTC: a circulating tumor cell detection platform using whole-cell MALDI-TOF MS fingerprinting in osteosarcoma

17 Jul 2026
0

Performance and pilot clinical validation of MALDITEC-CTC: a circulating tumor cell detection platform using whole-cell MALDI-TOF MS fingerprinting in osteosarcoma

Orrapin S, Sirikaew N, Chiangjong W, Chutipongtanate S, Teeyakasem P, Udomruk S, Moonmuang S, Sutthitthasakul S, Yongpitakwattana P, Phanphaisarn A, Suksakit P, Pasena A, Kamngoen R, Svasti J, Champattanachai V, Settakorn J, Pruksakorn D, Chaiyawat P*

Cancer Cell Int. 2026. doi: 10.1186/s12935-026-04386-0.

Tags

Share this

Related Posts

Recent Posts